Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 18 , ISSUE 12 ( December, 2014 ) > List of Articles

RESEARCH ARTICLE

Drug-induced anaphylactic reactions in Indian population: A systematic review

Tejas K. Patel,, Parvati B. Patel,, Manish J. Barvaliya,, C.B. Tripathi

Keywords : Anaphylaxis, causative drugs, hypersensitivity reactions, preventable reactions

Citation Information : Patel, TK, Patel, PB, Barvaliya, MJ, Tripathi C. Drug-induced anaphylactic reactions in Indian population: A systematic review. Indian J Crit Care Med 2014; 18 (12):796-806.

DOI: 10.4103/0972-5229.146313

License: CC BY-ND 3.0

Published Online: 01-12-2014

Copyright Statement:  Copyright © 2014; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background: Epidemiological data on drug-induced anaphylactic reactions are limited in India and are largely depending on studies from developed countries. Aim: The aim was to analyze the published studies of drug-induced anaphylaxis reported from India in relation with causative drugs and other clinical characteristics. Materials and Methods: The electronic databases were searched for Indian publications from 1998 to 2013 describing anaphylactic reactions. The information was collected for demographics, set up in which anaphylaxis occurred, causative drugs, incubation period, clinical features, associated allergic conditions, past reactions, co-morbid conditions, skin testing, IgE assays, therapeutic intervention and mortality. Reactions were analyzed for severity, causality, and preventability. Data were extracted and summarized by absolute numbers, mean (95% confidence interval [CI]), percentages and odds ratio (OR) (95% CI). Results: From 3839 retrieved references, 52 references describing 54 reactions were included. The mean age was 35.31 (95% CI: 30.52-40.10) years. Total female patients were 61.11%. Majority reactions were developed in perioperative conditions (53.70%), ward (20.37%) and home (11.11%). The major incriminated groups were antimicrobials (18.52%), nonsteroidal antiinflammatory drugs-(NSAIDs) (12.96%) and neuromuscular blockers (12.96%). Common causative drugs were diclofenac (11.11%), atracurium (7.41%) and β-lactams (5.96%). Cardiovascular (98.15%) and respiratory (81.48%) symptoms dominated the presentation. Skin tests and IgE assays were performed in 37.03% and 18.52% cases, respectively. The fatal cases were associated with complications (OR =5.04; 95% CI: 1.41-17.92), cerebral hypoxic damage (OR =6.80; 95% CI: 2.14-21.58) and preventable reactions (OR =14.33; 95% CI: 2.33-87.97). Conclusion: Antimicrobials, NSAIDs, and neuromuscular blockers are common causative groups. The most fatal cases can be prevented by avoiding allergen drugs.


PDF Share
  1. The epidemiology of anaphylaxis in Europe: A systematic review. Allergy 2013;68:1353-61.
  2. Hospital admissions for anaphylaxis in Istanbul, Turkey. Allergy 2013;68:128-30.
  3. A population-based epidemiologic study of emergency department visits for anaphylaxis in Florida. J Allergy Clin Immunol 2011;128:594-6001.
  4. Anaphylaxis: A review and update. Can Fam Physician 2010;56:1009-11.
  5. Anaphylaxis in the United States: An investigation into its epidemiology. Arch Intern Med 2001;161:15-21.
  6. Drug-induced anaphylaxis: Case/non-case study based on an Italian pharmacovigilance database. Drug Saf 2005;28:547-56.
  7. Severe drug-induced anaphylaxis: Analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010. Allergy 2013;68:929-37.
  8. Second symposium on the definition and management of anaphylaxis: Summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117:391-7.
  9. The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development. Glob Adv Health Med 2013;2:38-43.
  10. History and classification of anaphylaxis. Chem Immunol Allergy 2010;95:1-11.
  11. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
  12. Comment: Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2003;37:303-4.
  13. Cetirizine-induced anaphylaxis: A rare adverse drug reaction. Br J Clin Pharmacol 2009;67:577-8.
  14. Amoxicillin/clavulinic acid-induced anaphylaxis during anesthesia. J Anaesthesiol Clin Pharmacol 2012;28:531-2.
  15. Anaphylaxis following injection atracurium besylate: An uncommon but life threatening complication. Indian J Fundam Appl Life Sci 2013;3:211-3.
  16. Cefotaxime-induced near-fatal anaphylaxis in a neonate: A case report and review of literature. Indian J Pharmacol 2011;43:611-2.
  17. Anaphylaxis to cisplatin following nine previous uncomplicated cycles. Int J Clin Oncol 2002;7:365-7.
  18. Intraoperative anaphylaxis to inj ceftriaxone: Here we go again. Indian J Anaesth 2008;52:462.
  19. Late and acute reaction to iohexol, refractory to treatment. Indian J Anaesth 2011;55:631-3.
  20. Anaphylaxis to vecuronium: A rare event. Indian J Anaesth 2012;56:314-5.
  21. Tetanus toxoid induced anaphylaxis. J Vaccines Vaccin 2012;3:126.
  22. Anaphylaxis to artesunate? Indian J Crit Care Med 2012;16:55-7.
  23. Woman with supposed anaphylactic reaction. Persistent left superior vena cava. Ann Emerg Med 2012;59:98, 114.
  24. Anaphylaxis with midazolam - Our experience. Indian J Anaesth 2011;55:630-1.
  25. Intraoperative severe anaphylaxis due to gelofusine during a neurosurgical procedure. Anesth Analg 2007;104:238.
  26. Anaphylactic reaction due to paracetamol. J Indian Med Assoc 2004;102:223, 226.
  27. Severe anaphylactic reaction to atracurium. Indian J Pharmacol 2012;44:144-5.
  28. Palonosetron induced anaphylaxis in an adult female. Br J Clin Pharmacol 2010;70:149-50.
  29. Anaphylaxis to IV atropine: A case report. Indian J Clin Pract 2013;23:799-800.
  30. Anaesthetic management of a parturient with anaphylaxis to ranitidine. J Anaesth Clin Pharmacol 2010;26:410-2.
  31. Ciprofloxacin-induced anaphylactoid reaction. Eur J Pediatr 2006;165:573-4.
  32. A critical incident report: Propofol triggered anaphylaxis. Indian J Anaesth 2011;55:530-3.
  33. Life claiming anaphylaxis to intravenous ceftriaxone after negative skin test. Indian Anaesthetists′ Forum 2005;6:1-6.
  34. Successful resuscitation in a case of sudden cardiac arrest in an epileptic patient posted for spinal surgery. Anesth Essays Res 2013;7:123-6.
  35. Cardiac arrest following an anaphylactic reaction to atracurium. BMJ Case Rep 2010;2010.
  36. Fatal anaphylactic reaction to iron sucrose in pregnancy. Indian J Pharmacol 2013;45:93-4.
  37. Life threatening protamine reaction during bypass surgery - a case report. Indian Heart J 2009;61:216-7.
  38. Anaphylactic reaction to intravenous artesunate. J Assoc Physicians India 2009;57:183-4.
  39. Severe anaphylactic reaction in IgA deficient patient following transfusion of whole blood. Asian J Transfus Sci 2011;5:177.
  40. Compounded hypotension following spinal anaesthesia and anaphylaxis to 3.5% gelatin-a case report. Indian J Anaesth 2004;48:493-5.
  41. Anaphylactic reaction to intramuscular diclofenac. Case Rep Trop 2013;1:1-2.
  42. Pulseless electrical activity during caesarean delivery under spinal anaesthesia: A case report of severe anaphylactic reaction to Syntocinon. Int J Obstet Anesth 2009;18:85-8.
  43. An unusual cause of anaphylaxis during surgery. Indian J Crit Care Med 2013;17:396-7.
  44. Adverse reactions to 6% hydroxyethyl starch in the operating room. J Clin Diagn Res 2013;7:2656.
  45. Two cases of anaphylaxis under anaesthesia with vecuronium. Med J Armed Forces India 2013. [In Press]. Available from: http://www.mjafi.net/article/S0377-1237(13)00183-4/pdf. [Last accessed on 2014 Aug 10].
  46. Diclofenac induced fatal anaphylactic reaction. Indian Pediatr 1999;36:1067-9.
  47. Mephentermine triggered anaphylaxis in the peri-operative period: An unusual occurrence. Saudi J Anaesth 2013;7:219-20.
  48. Cortical blindness and paraplegia following hypoxic ischemic encephalopathy as a complication of common krait bite. Nepal J Ophthalmol 2011;3:206-9.
  49. Fatal anaphylactic reaction to oral diclofenac sodium. Can J Anaesth 2001;48:421.
  50. Antibiotic prophylaxis in cesarean section causing anaphylaxis and intrauterine fetal death. J Obstet Gynaecol Res 2008;34:252-4.
  51. A case report: Anaphylactic reaction to intravenous radiocontrast agent. B J Kines 2012;4:19-21. Available from: http://www.medadmbjmc.in/bjmc/docs/BJ_Kines_October_2012.pdf#page=21. [Last accessed on 2014 Aug 10].
  52. Cardiovascular collapse under spinalanesthesia. J South Asian Fed Obstet Gynecol 2009;1:67-9.
  53. IgE- and IgG mediated severe anaphylactic platelet transfusion reaction in a known case of cerebral malaria. Asian J Transfus Sci 2013;7:81-3.
  54. An experience with midazolam anaphylactoid reaction. J Anesth 2012;26:642-3.
  55. Anaphylaxis and hypersensitivity syndrome reactions in increasing severity following repeated exposure to tinidazole. J Postgrad Med 2005;51:243-4.
  56. Anaphylactic reaction to intravenous diclofenac. Indian J Crit Care Med 2011;15:37-9.
  57. Anaphylactic shock following intraurethral lidocaine administration during transurethral resection of the prostate. Indian J Urol 2008;24:114-5.
  58. Intraoperative anaphylaxis to ranitidine during cesarean section. J Nat Sci Biol Med 2013;4:257-9.
  59. Near fatal anaphylactic shock following iron sucrose injection for the treatment of anaemia. Int J Med Appl Sci 2013;2:28-31.
  60. Kounis syndrome resulting from anaphylaxis to diclofenac. Indian J Anaesth 2013;57:282-4.
  61. Anaphylaxis related to fentanyl citrate. J Emerg Trauma Shock 2012;5:257-61.
  62. Cardiac anaphylaxis: A case of acute ST-segment elevation myocardial infarction after IM epinephrine for anaphylactic shock. Am J Emerg Med 2013;31:1157.e1-3.
  63. Anaphylactoid reaction after use of intracervical dinoprostone gel. J Obstet Gynaecol Res 2014;40:833-5.
  64. Ranitidine anaphylaxis: A rare occurrence. Indian J Anaesth 2011;55:425-6.
  65. The International Collaborative Study of Severe Anaphylaxis. Epidemiology 1998;9:141-6.
  66. Risk of anaphylaxis in a hospital population in relation to the use of various drugs: An international study. Pharmacoepidemiol Drug Saf 2003;12:195-202.
  67. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 2001;87:549-58.
  68. Different risks for NSAID-induced anaphylaxis. Ann Pharmacother 2002;36:24-9.
  69. Drug-induced anaphylaxis survey in Portuguese Allergy Departments. J Investig Allergol Clin Immunol 2014;24:40-8.
  70. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003;99:536-45.
  71. Drug-induced anaphylaxis: A decade review of reporting to the Portuguese Pharmacovigilance Authority. Eur J Clin Pharmacol 2013;69:673-81.
  72. A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 1993;35:400-8.
  73. Paediatric anaphylaxis: A 5 year retrospective review. Allergy 2008;63:1071-6.
  74. Incidence of anaphylaxis and subtypes of anaphylaxis in a general hospital emergency department. J Investig Allergol Clin Immunol 2011;21:142-9.
  75. Drug-related fatal anaphylactic shock in Denmark 1968-1990. A study based on notifications to the Committee on Adverse Drug Reactions. J Clin Epidemiol 1995;48:1185-8.
  76. Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002). Ann Fr Anesth Reanim 2004;23:1133-43.
  77. Anaphylaxis during anesthesia in France: An 8-year national survey. J Allergy Clin Immunol 2011;128:366-73.
  78. Anaphylaxis during anesthesia: Results of a 12-year survey at a French pediatric center. Allergy 2005;60:828-34.
  79. Anaphylaxis to neuromuscular blocking drugs: Incidence and cross-reactivity in Western Australia from 2002 to 2011. Br J Anaesth 2013;110:981-7.
  80. Study of hypersensitivity reactions and anaphylaxis during anesthesia in Spain. J Investig Allergol Clin Immunol 2008;18:350-6.
  81. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000;30:1144-50.
  82. Food Allergy and Anaphylaxis Guidelines Group. Management of anaphylaxis: A systematic review. Allergy 2014;69:168-75.
  83. Epinephrine absorption in adults: Intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001;108:871-3.
  84. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010;126:477-80.e1.
  85. World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol 2013;162:193-204.
  86. Anaphylaxis during pregnancy. J Allergy Clin Immunol 2012;130:597-606.
  87. Allergic reactions during labour analgesia and caesarean section anaesthesia. Int J Obstet Anesth 2013;22:231-42.
  88. Brain injury due to anaphylactic shock as a result of formocresol used during root canal treatment. Int Endod J 2013;46:999-1005.
  89. Hypoxic brain damage after intramuscular self-injection of diclofenac for acute back pain. Eur J Anaesthesiol 2001;18:763-5.
  90. Fatal anaphylaxis with neuromuscular blocking agents: A risk factor and management analysis. Allergy 2014;69:954-9.
  91. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003;149:1018-22.
  92. Preventable drug related mortality in a Swedish population. Pharmacoepidemiol Drug Saf 2010;19:211-5.
  93. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions: A meta-analysis. PLoS One 2012;7:e33236.
  94. Nature of preventable adverse drug events in hospitals: A literature review. Am J Health Syst Pharm 2003;60:1750-9.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.